期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas LetPub Score 4.7
50 ratings
Rate
Reputation 5.7 Influence 3.4 Speed 7.0 | ||||||||||||||||||||||||||||
期刊簡稱 | B LATINOAM CARIBE PL | ||||||||||||||||||||||||||||
ISSN | 0717-7917 | ||||||||||||||||||||||||||||
h-index | 16 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 14.30%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://www.redalyc.org/revista.oa?id=856 | ||||||||||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||||||
出版商 | Universidad de Santiago de Chile | ||||||||||||||||||||||||||||
主題領域 | PHARMACOLOGY & PHARMACY | ||||||||||||||||||||||||||||
出版國/地區 | CHILE | ||||||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||||||
創刊年 | 2002 | ||||||||||||||||||||||||||||
每年文章數 | 60每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 89.81% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0717-7917%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:39:14 評論於 Try to conduct additional experiments whenever possible, and if not feasible, carefully consider reasons for defense, but always maintain a humble and cautious tone. After all, there is a certain rate of rejection for major revisions(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:45:07 評論於 When responding to the comments from reviewers, all questions must be answered one by one without omission; try to meet the requirements for additional experiments suggested in the comments, and provide reasonable reasons if unable to meet them; the literature recommended by reviewers must be cited and discussed thoroughly; after revising, make sure to check the corrections made in the original draft. If you agree with the modifications suggested by the journal editor when responding to their comments, simply accept the modifications. If you disagree, write down your reasons below the comments and provide feedback to the editor. If there is a disagreement between both parties, negotiate further(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 17:04:35 評論於 What are the differences between responding to reviewers' comments and responding to the editor's comments?(0) 讚! | Oswald Edie |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 15:06:56 評論於 The reviewer asked me to conduct additional experiments, but my samples have run out / the experiment has ended. Will my paper be rejected if I simply mention that my samples have run out?(0) 讚! | 龙鳞孝礼 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 11:05:09 評論於 As long as we can keep the journal indexed in SCI, that's all that matters. If the school starts calculating using CiteScore, there's nothing to worry about. On one hand, CiteScore includes a wider range of journals, so this journal will definitely be included. Additionally, it benefits smaller journals, and there won't be such a big difference for everyone. I hope the school adopts CiteScore(0) 讚! | 凌霄高洁 |
作者: 蒙德梦蕾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 12:27:27 評論於 Research Focus: Botany(0) 讚! | 蒙德梦蕾 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us